Sustango recall
SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.
Why was Sustango recalled?
Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot DAP272109, Exp: 4/1/2026
- Product
- SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.
- Recalling firm
- Ultra Supplement LLC
- Quantity
- 750 cartons
- Distribution
- Product was distributed nationwide in the USA via Amazon Marketplace on www.amazon.com.
- Recall date
- August 10, 2022
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)